AUDIT MicroControls, Inc. Announces Linearity FD Tumor Markers for Roche Systems

December 18, 2025 (Eatonton, GA) - AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Linearity FD Tumor Markers for Roche Systems. This product is intended to simulate human patient samples for use in determining linearity, calibration verification and verification of reportable range for AFP, CA 125, CA 15-3, CA 19-9, CEA, Total PSA.